Tech Company Financing Transactions
Spark Therapeutics Funding Round
Spark Therapeutics, based in Philadelphia, secured $72.8 million from Sofinnova Ventures, Rock Springs Capital and T. Rowe Price.
Transaction Overview
Company Name
Announced On
5/28/2014
Transaction Type
Venture Equity
Amount
$72,800,000
Round
Series B
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
3737 Market St.
Philadelphia, PA 19104
USA
Philadelphia, PA 19104
USA
Phone
Website
Email Address
Overview
Spark Therapeutics is developing one-time, life-altering gene therapy treatments to transform the lives of patients and re-imagine the treatment of debilitating diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jeffrey Marrazzo
Chief Financial Officer
Stephen Webster
Chief Operating Officer
John Furey
Chief Scientific Officer
Federico Mingozzi
VP - Bus. Development
Daniel Faga
VP - General Counsel
Joseph La Barge
VP - Human Resources
Lisa Dalton
VP - R & D
Katherine High
Browse more venture capital transactions:
Prev: 5/28/2014: Vizalytics Technology venture capital transaction
Next: 5/28/2014: Krossover venture capital transaction
Share this article
Where The Data Comes From
We report on all VC transactions involving tech companies. VC investment data records reported here come from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs